Article
Molecular subtyping of brain metastases and implications for therapy.
Current treatment options in oncology - 1 Dec 2013
Renfrow Jaclyn J, Lesser Glenn J
Abstract excerpt
OPINION STATEMENT: Molecular subtyping of tumors and treatment with specifically targeted therapy is a rapidly developing trend in oncology. Genetic and protein biomarkers impact biological behavior, patient prognosis, and inform treatment options. Select examples include EGFR mutations in primary non-small cell lung cancers, Her2 overexpression in breast cancer, and BRAF mutations in melanoma. Systemic benefit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
